Idiopathic thrombocytopenic purpura
Also called: ITP and immune thrombocytopenic purpura
Low levels of the blood cells that prevent bleeding (platelets).
- Treatable by a medical professional
- Requires a medical diagnosis
- Lab tests or imaging always required
ITP may occur when the immune system mistakenly attacks platelets. In children, it may follow a viral infection. In adults, it may be chronic.
Rare: Fewer than 200,000 US cases per year
Consult a doctor for medical advice
Sources: Mayo Clinic and others. Learn more
People also ask
What is the difference between aTTP and iTTP?
What causes ITP to flare up?
Is ITP an autoimmune disorder?
What are the symptoms of TTP?
Oct 28, 2020 · Auto-immune thrombotic thrombocytopenic purpura (iTTP) is a rare, life-threatening disorder caused by auto-antibodies against ADAMTS13. It is ...
Jan 19, 2023 · Immune thrombocytopenic purpura (iTTP) is a near-fatal disease unless immediate treatment is initiated with the current recommended ...
This article focuses on the treatment for immune thrombotic thrombocytopenic purpura (iTTP) in the form of plasma exchange.
Jul 26, 2022 · Modern therapy for acute TTP has resulted in a dramatic improvement in outcomes, with the combination of plasma exchange, immunosuppression, ...
Acquired/immune-mediated thrombotic thrombocytopenic purpura (aTTP & iTTP) is a rare blood disorder with life-threatening consequences.
Thrombotic thrombocytopenia purpura (TTP) is a rare, serious blood disease. Major symptoms may include a severe decrease in the number of blood platelets ( ...
Nov 28, 2023 · Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is defined by thrombocytopenia and microangiopathic hemolytic anemia without an ...
Jan 27, 2022 · The mission* of the Interagency Trusted Tester Program is to promote a unified, consistent, sharable, and repeatable test and evaluation ...
CABLIVI (caplacizumab-yhdp) is a prescription medicine used for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP), in combination ...
Jan 18, 2024 · TPE, immunosuppressive agents, and caplacizumab are currently the standard treatment approaches for the first or relapsing episodes of iTTP.